In agreement with this, active E2F1/BRD4 transcriptional programs have been identified in prostate cancer cells [72] and cellular data have documented direct effects of BET proteins on E2F1 transcriptional activities [43]. The gene discussed is BRD4; the disease is prostate carcinoma.